Investor World Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor World Review.

Press releases published on October 2, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HireQuotient’s EasySource Elevated to Featured Listing on Paylocity Marketplace Within a Month of Launching
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
Aura Minerals Announces Mining Fleet Insourcing at Apoena, Almas and Borborema
Hub Group Announces Changes to Board of Directors
Published Human Research Gives Family Caregivers a Way to Evaluate Joint Supplements
MTY Food Group Inc Will Hold a Conference Call to Discuss Its 2026 Third Quarter Results
Groupe d'alimentation MTY inc tiendra une téléconférence pour discuter les résultats de son troisième trimestre 2026
Alta Equipment Group Announces Preferred Stock Dividend
Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week
CECO Environmental to Transfer U.S. Stock Exchange Listing to the Texas Stock Exchange
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
Plexrum Protocol Deploys Sepolia Testnet Prototype for Real Estate Record and Token Workflow Testing
Transaction in Own Shares
WasabiCard to Convene Circle, Visa and Payments Leaders at TOKEN2049
The Ensign Group Adds New Operations in Colorado

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Investor World Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.